-
Innovation Ranking
NewInnovation Ranking – Element Solutions Inc
Element Solutions Inc (Element Solutions) is a diversified producer of high-technology specialty chemical products. The company's products include water-based hydraulic control fluids, surface and coating materials, photopolymers, and crop protection products which comprise fungicides, herbicides and insecticides. It offers its chemicals and processes to various industries which include agriculture, automotive, electronics, graphic arts, metals, plastic plating, animal health and offshore oil and gas production and drilling. Element Solutions also offers technical services. It markets its products under various brands including...
-
Product Insights
NewLikelihood of Approval Analysis for Allergies
Overview How likely is it that the drugs in Allergies will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Allergies Overview Allergies result from an immune system reaction to substances that typically...
-
Company Insights
Innovation and Patenting activity of Element Solutions Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Element Solutions Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LY-3885125 in Dyslipidemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LY-3885125 in Dyslipidemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LY-3885125 in Dyslipidemia Drug Details: LY-3885125 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CAN-3110 in High-Grade Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CAN-3110 in High-Grade Glioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CAN-3110 in High-Grade Glioma Drug Details: RQNestin-34.5v.2 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LY-3885125 in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LY-3885125 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LY-3885125 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Drug Details: LY-3885125 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CAN-3110 in Recurrent Glioblastoma Multiforme (GBM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CAN-3110 in Recurrent Glioblastoma Multiforme (GBM) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CAN-3110 in Recurrent Glioblastoma Multiforme (GBM) Drug Details: RQNestin-34.5v.2 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LY-3885125 in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LY-3885125 in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LY-3885125 in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – QBS-10072S in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - QBS-10072S in Metastatic Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. QBS-10072S in Metastatic Breast Cancer Drug Details: QBS-10072S is under development...
-
Thematic Analysis
Edtech – Thematic Intelligence
Edtech Thematic Intelligence Report Overview Education technology (EdTech) gained prominence during the COVID-19 pandemic as travel restrictions forced schools and other educational institutions to teach online. The technologies that comprise edtech include artificial intelligence (AI), which aids in content creation, the customization of learning processes, evaluating performances, ensuring real-time communication, and automating grading. Additionally, VR and AR create appealing environments for students through virtual elements and situations. In an AR and VR classroom setup, both teachers and students perform tasks...